Dr. Paul Sax weighs in on the “often polarizing” physician appointed to lead CBER in
HIV and ID Observations.
In the latest HIV and ID Observations, Dr. Paul Sax communicates his hopes for — and concerns about — the new head of the FDA's Center for Biologics Evaluation and Research (CBER).
Do you want to be notified whenever Dr. Sax posts? Sign up to receive notifications by email by using the Follow Via Email box.
Want to see more from NEJM Journal Watch? Register here.